Compare HLIO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLIO | RLAY |
|---|---|---|
| Founded | 1970 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 1996 | 2020 |
| Metric | HLIO | RLAY |
|---|---|---|
| Price | $76.96 | $12.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $66.17 | $19.50 |
| AVG Volume (30 Days) | 263.5K | ★ 2.8M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | 23.93 | ★ 31.78 |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $200,727,000.00 | $15,355,000.00 |
| Revenue This Year | $3.67 | N/A |
| Revenue Next Year | $5.00 | $324.03 |
| P/E Ratio | $130.90 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $28.79 | $2.75 |
| 52 Week High | $80.00 | $17.32 |
| Indicator | HLIO | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 63.79 | 39.74 |
| Support Level | $63.09 | $11.75 |
| Resistance Level | N/A | $17.32 |
| Average True Range (ATR) | 2.66 | 0.73 |
| MACD | 1.06 | -0.23 |
| Stochastic Oscillator | 81.14 | 22.55 |
Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.